Vividion Therapeutics, created in 2016 (United States), from 2081 sister brands and 17477 competing brands. The Vividion Therapeutics brand is owned by BAYER, a company listed in Francfort. The International Securities Identification Number (ISIN) of BAYER is DE000BAY0017. The sector of Vividion Therapeutics is Drug Manufacturers.
Investment simulator :
Portfolio valuation
BAYER
(Vividion Therapeutics)
over 5 years*
EUR 12.10